HOME > MARKETS > COMPANY NEWS
  COMPANY NEWS
COMPANY
Alembic Pharmaceuticals reports marginal fall in Q3 consolidated net profit
Feb-05-2026

Alembic Pharmaceuticals has reported results for third quarter ended December 31, 2025 (Q3FY26).

The company has reported 33.40% rise in its net profit at Rs 114.47 crore for the third quarter ended December 31, 2025 as compared to Rs 85.81 crore for the same quarter in the previous year. Total income of the company increased by 16.28% at Rs 1652.97 crore for Q3FY26 as compared to Rs 1421.55 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 3.93% fall in its net profit at Rs 132.97 crore for the third quarter ended December 31, 2025 as compared to Rs 138.42 crore for the same quarter in the previous year. However, total income of the company increased by 11.13% at Rs 1891.81 crore for Q3FY26 as compared to Rs 1702.25 crore for the corresponding quarter previous year.

  RELATED NEWS >>